Skip to main content
. 2015 Apr 22;89(13):6874–6886. doi: 10.1128/JVI.00528-15

FIG 1.

FIG 1

Schematic diagram of the experimental approach. HeLa cells were infected with VACV WR at a multiplicity of 20 PFU/cell. Cycloheximide, harringtonine, or lactimidomycin was added at 2, 4, and 8 h postinfection, and mRNAs protected by ribosomes from digestion with RNase I were isolated and deep sequenced (ribosome profiling). Total mRNA in the presence of cycloheximide was simultaneously isolated, fragmented by digestion with RNase III, and deep sequenced (mRNA profiling).

HHS Vulnerability Disclosure